Improving Outcomes in Patients with Acute Coronary Syndrome

Performance Improvement (PI) CME Activity

The University of Chicago Pritzker School of Medicine’s Improving Outcomes in Patients with Acute Coronary Syndrome is a complementary, online Performance Improvement (PI) CME activity that provides cardiologists, hospitalists, and emergency medicine physicians nationwide the tools to measure quality of care and to identify opportunites to improve the care and outcomes of patients with Acute Coronary Syndrome.

Participants in this AMA-standardized, 3-Stage PI activity will assess their current practice by submitting data on STEMI and NSTEMI patients and receive confidential self-assessment reports on how their practice compares to the evidence-based ACC/AHA 2008 Performance Measures for Adults with ST-Elevation and Non ST-Elevation Myocardial Infarction. Participants will then formulate and implement an improvement plan based on guidelines and reassess their practice and report on changes from the initial assessment. Throughout this activity participants will have access to expert faculty Mentors to answer their ACS-related questions.

Earn up to 20 AMA PRA Category 1 Credits™

This is the perfect time to take part in PI CME activities as Maintenance of Certification and Maintenance of Licensure have mandatory requirements for practice improvement self-assessments. Stay ahead of the quality curve. Participate and use the data from the nationally recognized quality measures in this PI CME activity to complete ABIM’s Self-Directed PIM and earn ABIM Maintenance of Certification credits.

Get Started

To learn more, click here for a list of FAQs.

PI CME Participants

You can access this site by tapping the “iMD” icon on your smartphone screen.

Or you may use this web browser by clicking on the above icon.

This continuing medical education activity is sponsored by the University of Chicago.	This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, Inc. and an independent educational grant from Genentech, a member of the Roche Group.